1. Inhibition by doxycycline of angiogenesis in the chicken chorioallantoic membrane (CAM)

   • Mary Richardson
   • David Wong
   • Gurmit Singh

   Original Article 22 February 2005 Pages: 1 - 9

   

2. Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study

   • Do Hyoung Lim
   • Young Suk Park
   • Keunchil Park

   Original Article 22 March 2005 Pages: 10 - 14

   

3. A novel phospholipid gemcitabine conjugate is able to bypass three drug-resistance mechanisms

   • Richard L. Alexander
   • Bryan T. Greene
   • Gregory L. Kucera

   Original Article 24 March 2005 Pages: 15 - 21

   

4. Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer

   • Jun Murakami
   • Jun-ichi Asaumi
   • Kanji Kishi

   Original Article 25 March 2005 Pages: 22 - 28

   

5. Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells

   • Natasha Kekre
   • Carly Griffin
   • Siyaram Pandey

   Original Article 22 February 2005 Pages: 29 - 38

   

6. A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109

   • Peter J. Van Veldhuizen
   • James R. Faulkner
   • E. David. Crawford

   Original Article 25 March 2005 Pages: 39 - 45

   

7. Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib

   • Bridget N. Fahy
   • Michael G. Schlieman
   • Richard J. Bold

   Original Article 25 March 2005 Pages: 46 - 54

   

8. Hyperthermic isolated regional perfusion with CDDP for bone and soft-tissue sarcoma of the lower limb: pharmacokinetics, thermal dose, toxicity, and feasibility

   • Satoshi Abe
   • Toru Tokizaki
   • Takashi Matsushita

   Original Article 25 March 2005 Pages: 55 - 62

   

9. American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats

   • Sangeeta Mehendale
   • Han Aung
   • Chun-Su Yuan

   Original Article 25 March 2005 Pages: 63 - 69

   

10. In vivo antitumor activity by 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone in a solid human carcinoma xenograft model

    • Chun-Lin Ye
    • Jian-Wen Liu
    • Feng Qian

    Original Article 02 April 2005 Pages: 70 - 74

    

11. Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule

    • Agustin A. Garcia
    • Mahesh Pujari
    • Stan Louie

    Original Article 05 April 2005 Pages: 75 - 82

12. Properties of recombinant human N¹-acetylpolyamine oxidase (hPAO): potential role in determining drug sensitivity

    • Yanlin Wang
    • Amy Hacker
    • Robert A. Casero Jr

    Original Article 25 March 2005 Pages: 83 - 90

    

13. Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy

    • Toshiaki Sendo
    • Naoko Sakai
    • Ryozo Oishi

    Original Article 25 March 2005 Pages: 91 - 96

    

14. Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck

    • Jeffrey R. Jaglowski
    • Ian S. Zagon
    • Patricia J. McLaughlin

    Original Article 25 March 2005 Pages: 97 - 104

    

15. Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer

    • Selvanathan Saravana Perumal
    • Palanivelu Shanthi
    • Panchanadham Sachdanandam

    Original Article 22 February 2005 Pages: 105 - 114